Cahyaningrum, Ayu Wastuti POLA PERESEPAN OBAT PADA PASIEN COVID-19 DENGAN PENYERTA KARDIOVASKULER DI RST DR.SOEPRAOEN. Diploma (D3) thesis, ITSK RS dr. Soepraoen.
|
Text
ABSTRAK.pdf Download (380kB) | Preview |
|
|
Text
BAB I.pdf Download (195kB) | Preview |
|
|
Text
BAB II.pdf Download (339kB) | Preview |
|
|
Text
BAB III.pdf Download (421kB) | Preview |
|
|
Text
BAB IV.pdf Download (336kB) | Preview |
|
|
Text
BAB V.pdf Download (382kB) | Preview |
|
|
Text
LAMPIRAN.pdf Download (695kB) | Preview |
Abstract
Dari total kasus yang positif COVID-19, sebanyak 1.488 pasien tercatat memiliki penyakit penyerta. Gangguan kardiovaskuler merupakan komplikasi pada pasien COVID-19. Peneliti menggunakan metode observasional non eksperimental secara deskriptif. Pengamatan dilakukan secara retrospektif pendekatan cross sectional. Pengambilan data sekunder dari lembar resep pengobatan pasien COVID-19 periode Juli 2021 – September 2021 diperoleh sampel 51 pasien memenuhi kriteria inklusi. Berdasarkan hasil penelitian, diperoleh karakteristik usia dan jenis kelamin pasien COVID-19 terbanyak usia 45-65 tahun sebanyak 23 orang (45,1%), pasien laki-laki sebanyak 28 orang (54,9%). Peresepan antibiotik Meropenem sebanyak 34 peresepan (14,34%), berdasarkan penggolongan obat untuk terapi COVID-19 paling banyak Vitamin 81 peresepan (34,18%). peresepan Atorvastatin sebanyak 27 peresepan dan Candesartan sebanyak 27 peresepan (27,56%), golongan obat kardiovaskuler paling banyak golongan Disiplidemia 30 peresepan (30,50%). Terapi kombinasi 6 golongan obat sebanyak 15 peresepan (29,4%) dengan pemberian terbanyak yaitu Antibiotik + Vitamin + Antivirus + Antikoagulan + Kortikosteroid + Disiplidemia. ABSTRACT Of the total positive cases of COVID-19, 1,488 patients were recorded to have co-morbidities. Cardiovascular disorders are a complication in COVID- 19 patients. The researcher used a descriptive non-experimental observational method. Observations were carried out retrospectively with a cross sectional approach. Secondary data collection from the COVID-19 patient prescription sheet for the period July 2021 – September 2021, obtained a sample of 51 patients who met the inclusion criteria. Based on the results of the study, the age and sex characteristics of COVID-19 patients were 23 people (45.1%), most of the patients were 28 people (54.9%). There were 34 prescriptions for the antibiotic Meropenem (14.34%), based on the classification of drugs for the treatment of COVID- 19 with the most Vitamin 81 prescriptions (34.18%). There are 27 prescriptions for Atorvastatin and 27 prescriptions for Candesartan (27.56%), the most cardiovascular drug group is the Disciplidemia group with 30 prescriptions (30.50%). Combination therapy of 6 drug classes was 15 prescriptions (29.4%) with the most administration, namely Antibiotics + Vitamins + Antivirus + Anticoagulants + Corticosteroids + Disciplidemia.
| Item Type: | Thesis (Diploma (D3)) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Contributors: |
|
||||||||||||
| Uncontrolled Keywords: | Pola Peresepan, COVID-19, Kardiovaskuler; Prescribing Pattern, COVID-19, Cardiovascular | ||||||||||||
| Divisions: | Pharmacy Study Program | ||||||||||||
| Depositing User: | Yacobus Sudaryono | ||||||||||||
| Date Deposited: | 23 Nov 2022 03:31 | ||||||||||||
| Last Modified: | 23 Aug 2023 03:47 | ||||||||||||
| URI: | http://repository.itsk-soepraoen.ac.id/id/eprint/752 |
Actions (login required)
 |
View Item |